Inherited Retinal Disease Program

Sponsored, no-charge genetic testing
US and Canada

Inherited Retinal Disease

What is the Inherited Retinal Disease program?

Sponsored, no-charge genetic testing for individuals suspected of or at risk of having an inherited retinal disease (IRD) either from clinical symptoms or family history.

About Inherited Retinal Disease

What are IRDs?

Inherited retinal diseases (IRDs) are a genetically and clinically heterogeneous group of disorders characterized by loss of photoreceptor function and a major cause of severe vision loss or blindness.1
Learn more

Incidence of IRDs

The incidence of IRDs is estimated to be 1:2000 and the leading cause of vision loss between the ages of 15 and 45.1
Learn more

IRDs can present in various forms:

  • Retinitis pigmentosa (RP) is the most common presentation. RP typically presents with night blindness followed by constriction of peripheral visual fields, which leads to tunnel vision and eventually loss of central vision.2
  • Patients with cone-rod dystrophies (CRD) experience decreased visual acuity, photophobia, nystagmus and progressive loss of color perception. Onset for CRD is typically in early childhood or adolescence.3,4
  • Leber congenital amaurosis (LCA) is a severe retinal disease with early onset and is characterized by early vision loss in infancy, absent or sluggish pupillary response, and severely abnormal or absent ERG response.5,6
  • Extra ocular involvement that may require additional medical management can also present in individuals with an underlying genetic syndrome with features that include but are not limited to renal disease, developmental delay or intellectual disability, hearing loss, ataxia, laterality defects and abnormalities of the skeletal, cardiac and genitourinary systems.

Inherited Retinal Disease sponsored testing can help:

  • Confirm a suspected diagnosis
  • Provide treatment guidance
  • Support enrollment in precision therapy clinical trials
  • Determine which relatives may be at risk

Program eligibility

This program is available to patients in the USA and Canada suspected of having an inherited retinal disease based on one or more of the following:

  • Symptomatic individual with clinical diagnosis or suspicion of one of the following:

    • Retinitis pigmentosa (RP)
    • Cone Rod Dystrophy (CRD)
    • Leber congenital amaurosis (LCA)
    • Stargardt disease (STGD)
    • Other inherited retinal disease
  • Or symptomatic individual with suspicion of an inherited retinal disease

  • Or asymptomatic individual with a family history of known disease-causing variant in one of the genes included on the Invitae Inherited Retinal Disorders Panel

  • Or asymptomatic individual with a family history of an inherited retinal disease with no previous genetic testing

Note: This program is not appropriate for patients with age-related macular degeneration.

Test options

This program offers testing with the following panel. Learn more about the panel in our test catalog before placing your order on this program page.

How to order

Our easy-to-order panels align with professional guidelines, making your potential next steps clearer.

  • Step 1 duotone icon

    Step 1

    Discuss testing and get consent from the eligible patient. Place your order via our convenient online portal.

  • Step 2 duotone icon

    Step 2

    Collect your patient’s specimen using an Invitae collection kit and return it. Use the label provided to ship most samples at no additional charge from the US and Canada.

  • Genetic testing expert - Invitae icon

    Step 3

    Receive results online and access resources to guide your discussion with patient about their results.

Next steps and additional services

Woman smiling while providing genetic expert support

Genetic counseling services

Individuals in the US and Canada tested through this program are eligible for post-test genetic counseling to help them understand their test results. This service is made available by Invitae at no charge as part of the program.

Patients can access genetic counseling by using an online scheduling option or by contacting Invitae Client Services at 1-800-436-3037 and asking to schedule a genetic counseling appointment.

References
1. Cremers FPM, Boon CJF, Bujakowska K, Zeitz C. Special Issue Introduction: Inherited Retinal Disease: Novel Candidate Genes, Genotype-Phenotype Correlations, and Inheritance Models. Genes (Basel). 2018;9(4):215. Published 2018 Apr 16. doi:10.3390/genes9040215.
2. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125(2):151-158. doi:10.1001/archopht.125.2.151.
3. Moore AT. Cone and cone-rod dystrophies. J Med Genet. 1992;29(5):289-290. doi:10.1136/jmg.29.5.289.
4. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis. 2007;2:7. Published 2007 Feb 1. doi:10.1186/1750-1172-2-7.
5. Chacon-Camacho OF, Zenteno JC. Review and update on the molecular basis of Leber congenital amaurosis. World J Clin Cases. 2015;3(2):112-124. doi:10.12998/wjcc.v3.i2.112.
6. Fazzi E, Signorini SG, Scelsa B, Bova SM, Lanzi G. Leber's congenital amaurosis: an update. Eur J Paediatr Neurol. 2003;7(1):13-22. doi:10.1016/s1090-3798(02)00135-6.


Disclaimer: This is a sponsored testing program. While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified (pseudonymized) patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.